Largest health care companies by earnings

Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.

Johnson & Johnson leads the 170 health care companies ranked by earnings, at £20.5B, ahead of Eli Lilly (£15.8B) and Merck & Co (£13.9B). Figures as of 19 Nov 2026, 22:37 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
170
First
Johnson & Johnson£20.5B
Median
£207.8M
Combined market value
£6.81T
Countries
14

Market values as of .

All countries
Health Care
All categories
GBP
Clear filters
Largest health care companies by earnings
#CompanyEarnings ↓Market capPriceToday1 yearPrice, 30 daysCountry
101Hims & Hers HealthHIMS · Health Care£98.1M£2.9B£12.24 6.04% down 49% down United States
102Ligand PharmaceuticalsLGND · Health Care£95.1M£4.4B£219.18 3.94% down 50% up United States
103Corcept TherapeuticsCORT · Health Care£76.1M£5.4B£49.63 4.15% down 10% down United States
104HaemoneticsHAE · Health Care£74.3M£4.2B£91.94 2.03% down 64% up United States
105Amneal PharmaceuticalsAMRX · Health Care£55M£5.7B£16.34 2.24% down 90% up United States
106Kiniksa Pharmaceuticals InternationalKNSA · Health Care£45.1M£5.6B£71.45 1.59% down 129% up United Kingdom
107RepligenRGEN · Health Care£37.3M£8.3B£130.07 1.38% down 12% up United States
108LifeStance Health GroupLFST · Health Care£7.4M£3.9B£10.19 3.12% down 123% up United States
109BillionToOneBLLN · Health Care£5.7M£3.3B£68.90 1.46% down 4% down United States
110Arrowhead PharmaceuticalsARWR · Health Care-£1.2M£4.7B£33.34 1.25% up 13% up United States
111BrukerBRKR · Health Care-£6.6M£7.2B£47.43 1.83% down 44% up United States
112RadNetRDNT · Health Care-£14.2M£4.2B£53.09 3.22% down 9% down United States
113Mirum PharmaceuticalsMIRM · Health Care-£17.8M£4.8B£72.95 3.27% up 34% up United States
114Travere TherapeuticsTVTX · Health Care-£19.5M£3.5B£36.89 3.86% down 45% up United States
11510x GenomicsTXG · Health Care-£33.3M£5.8B£43.83 0.54% up 247% up United States
116Adaptive BiotechnologiesADPT · Health Care-£45.4M£3.5B£21.43 1.44% down 74% up United States
117Caris Life SciencesCAI · Health Care-£52M£4.1B£14.16 4.92% down 19% down United States
118VeradermicsMANE · Health Care-£53.5M£4B£95.01 0.38% down 231% up United States
119Belite BioBLTE · Health Care-£59.3M£4.7B£115.36 3.33% down 43% up United States
120Twist BioscienceTWST · Health Care-£59.3M£5.8B£85.26 4.07% down 346% up United States
121Oruka TherapeuticsORKA · Health Care-£80.5M£5.1B£74.53 1.91% up 255% up United States
122HeartflowHTFL · Health Care-£89.2M£3B£34.09 2.75% down 66% up United States
123ErascaERAS · Health Care-£95.1M£3.8B£10.86 3.34% up 395% up United States
124Protagonist TherapeuticsPTGX · Health Care-£99.4M£6.2B£94.73 2.47% down 51% up United States
125Charles River Laboratories InternationalCRL · Health Care-£110.3M£12B£250.49 1.60% down 106% up United States
126Spyre TherapeuticsSYRE · Health Care-£118.6M£7.1B£74.57 3.77% down 332% up United States
127CG OncologyCGON · Health Care-£123M£5.6B£62.56 2.38% up 97% up United States
128Dianthus TherapeuticsDNTH · Health Care-£124M£3.6B£64.80 1.01% up 108% up United States
129Edgewise TherapeuticsEWTX · Health Care-£128.2M£3.4B£31.45 0.48% down 86% up United States
130Axsome TherapeuticsAXSM · Health Care-£139.9M£5.5B£103.64 1.25% up 6% down United States
131Definium TherapeuticsDFTX · Health Care-£140.4M£3.1B£22.52 1.24% up 168% up United States
132GlaukosGKOS · Health Care-£143.4M£10.8B£181.87 2.15% up 145% up United States
133Rhythm PharmaceuticalsRYTM · Health Care-£150.1M£6.2B£89.22 1.88% down 18% up United States
134NateraNTRA · Health Care-£159M£32.1B£221.45 0.15% up 28% up United States
135Kodiak SciencesKOD · Health Care-£175.7M£4.9B£74.78 0.09% up 399% up United States
136Elanco Animal HealthELAN · Health Care-£177.2M£10B£20.08 1.54% down 26% up United States
137LivaNovaLIVN · Health Care-£185.2M£3.9B£70.33 2.61% down 77% up United Kingdom
138Ascendis PharmaASND · Health Care-£193.3M£12.8B£195.51 5.32% down 29% up Denmark
139Madrigal PharmaceuticalsMDGL · Health Care-£220.2M£7B£303.05 0.34% down 27% down United States
140Legend BiotechLEGN · Health Care-£226.7M£2.4B£12.30 0.92% down 41% down United States
141Roivant SciencesROIV · Health Care-£229M£21.6B£29.76 0.59% up 91% up United Kingdom
142Praxis Precision MedicinesPRAX · Health Care-£231.6M£6.6B£237.48 1.87% up 86% up United States
143Kymera TherapeuticsKYMR · Health Care-£237.8M£7.8B£91.19 1.44% down 87% up United States
144Cogent BiosciencesCOGT · Health Care-£251.3M£3.7B£21.19 0.25% down 20% down United States
145MiniMed GroupMMED · Health Care-£254.4M£3.5B£12.42 4.30% down 8% down United States
146ImmunityBioIBRX · Health Care-£268.4M£5.3B£5.02 1.94% down 232% up United States
147Jazz PharmaceuticalsJAZZ · Health Care-£272M£11.6B£180.61 4.57% down 41% up Ireland
148Bausch + LombBLCO · Health Care-£275M£5.6B£15.80 1.24% down 44% up Canada
149ABIVAXABVX · Health Care-£284.8M£5.4B£61.60 3.79% down 32% down France
150Scholar Rock HoldingSRRK · Health Care-£288.7M£4.7B£38.47 4.94% up 26% up United States
151Ionis PharmaceuticalsIONS · Health Care-£291.3M£3.5B£20.79 0.62% down 63% down United States
152GRAILGRAL · Health Care-£311.9M£3.6B£80.08 2.68% up 19% up United States
153Guardant HealthGH · Health Care-£318M£15B£111.21 0.31% up 45% up United States
154Oscar HealthOSCR · Health Care-£338.5M£6.2B£19.99 5.08% down 112% up United States
155ImmunovantIMVT · Health Care-£386.2M£5.1B£24.84 1.96% down 46% up United States
156AvantorAVTR · Health Care-£405M£7.8B£11.55 1.63% down 40% up United States
157CRISPR TherapeuticsCRSP · Health Care-£444.2M£2.9B£29.74 3.14% down 18% down Switzerland
158BridgeBio PharmaBBIO · Health Care-£559.8M£11.6B£59.72 0.22% up 21% up United States
159VaxcytePCVX · Health Care-£585.6M£7.1B£44.58 0.27% down 23% up United States
160CytokineticsCYTK · Health Care-£599.6M£5.5B£39.31 0.27% up 19% down United States
161TeleflexTFX · Health Care-£691.8M£5B£124.81 1.48% down 58% up United States
162Takeda PharmaceuticalTAK · Health Care-£729M£52.2B£16.35 0.66% up 51% up Japan
163Baxter InternationalBAX · Health Care-£731M£10B£19.39 2.94% down 50% up United States
164Summit TherapeuticsSMMT · Health Care-£824.6M£6.5B£8.07 0.67% up 36% down United States
165Revolution MedicinesRVMD · Health Care-£864.1M£26.3B£121.78 0.24% down 129% up United States
166BioNTechBNTX · Health Care-£962.8M£15.4B£62.16 2.26% down 14% down Germany
167InsmedINSM · Health Care-£975.3M£24.2B£110.34 20.58% up 40% down United States
168ModernaMRNA · Health Care-£2.2B£61.6B£152.26 1.29% up 780% up United States
169ViatrisVTRS · Health Care-£2.7B£17.4B£15.19 1.97% down 99% up United States
170CenteneCNC · Health Care-£5.1B£24.8B£50.09 2.77% down 94% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.7638 GBP).

Questions and answers

Which health care companies rank first by earnings?

Johnson & Johnson (£20.5B), Eli Lilly (£15.8B) and Merck & Co (£13.9B) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 22:37 UTC.

How many health care companies are in this ranking?

170 are ranked by earnings.

What are these health care companies worth together?

The 170 health care companies ranked by earnings have a combined market value of £6.81T as of 19 Nov 2026, 22:37 UTC.

What does ranking by earnings measure?

Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.

Cite this page

Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings

Underlying data: Yahoo Finance; SEC EDGAR.